切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2018, Vol. 07 ›› Issue (04) : 221 -224. doi: 10.3877/cma.j.issn.2095-3259.2018.04.007

所属专题: 文献

专家论坛

早产的治疗
陈艳红1, 陈敦金1,()   
  1. 1. 510150 广州医科大学附属第三医院妇产科
  • 收稿日期:2018-07-22 出版日期:2018-11-18
  • 通信作者: 陈敦金
  • 基金资助:
    国家重点研发计划资助(2016YFC1000405); 国自然科学基金重点项目(81830045)

Treatment of preterm birth

Yanhong Chen1, Dunjin Chen1()   

  • Received:2018-07-22 Published:2018-11-18
  • Corresponding author: Dunjin Chen
引用本文:

陈艳红, 陈敦金. 早产的治疗[J/OL]. 中华产科急救电子杂志, 2018, 07(04): 221-224.

Yanhong Chen, Dunjin Chen. Treatment of preterm birth[J/OL]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2018, 07(04): 221-224.

早产是导致全球新生儿死亡和并发症的主要原因,早产儿的并发症给家庭和社会带来沉重的负担,因此是围产医学领域关注的重点。近年来,随着医疗水平的提高,早产的治疗和监护措施也在不断改进,并有效地改善了围产儿结局。本文将对早产的治疗进行论述。

Preterm birth is a major cause of neonatal death and complications worldwide. The complications of premature infants bring a heavy burden on families and society. Therefore, it catches the focus of attentions in perinatal medicine. In recent years, with the improvement of medical level, the treatment and monitoring measures for preterm birth have been continuously improved, and the perinatal outcome has been effectively improved. This paper discusses the treatment of preterm birth.

[1]
Committee on Practice Bulletins-Obstetrics. Management of preterm labor. Practice Bulletin No.171. American College of Obstetricians and Gynecologists [J]. Obstet Gynecol, 2016, 128(4): e155-e164.
[2]
Loïc S, Marie-Victoire S, Pierre-Yves A, et al. Prevention of spontaneous preterm birth: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians [J]. Eur J Obstet Gynecol Reprod Biol, 2016, 30(210): 217-224.
[3]
Vogel JP, Chawanpaiboon s, Watananirun K, et al. Global regional and national levels and trends of preterm birth rates for 1990 to 2014: protocol for development of World Health Organization estimates [J]. Reprod Health, 2016, 13(1): 76.
[4]
Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial [J]. Lancet, 2008, 372(9646): 1319-1327.
[5]
Witter FR, Zimmerman AW, Reichmann JP, et al. In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes [J]. Am J Obstet Gynecol, 2009, 201(6): 553-559.
[6]
World Health Organization.WHO recommendations on interventions to improve preterm birth outcomes. Geneva: World Health Organization [EB/OL]. [2015-8-15].

URL    
[7]
RCOG. Tocolysis for women in preterm labour, Green-top Guildline No.1b, London, RCOG[EB/OL]. [2014-024)5].

URL    
[8]
Sood BG, Lulic-Botica M, Holzhausen KA, et al. The risk of necrotizing enterocolitis after indomethacin tocolysis [J]. Pediatrics, 2011, 128(1): e54-e62.
[9]
Soraisham AS, Dalgleish S, Singhal N. Antenatal indomethacin tocolysis is associated with an increased need for surgical ligation of patent ductus arteriosus in preterm infants [J]. J Obstet Gynaecol Can, 2010, 32(5): 435-442.
[10]
Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour [J]. Cochrane Database Syst Rev, 2010, (7): CD000940.
[11]
Sotiriadis A, Tsiami A, Papatheodorou S, et al. Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta analysis [J]. Obstet Gynecol, 2015, 125(6): 1385-1389.
[12]
Periviable Birth. Obstetric Care Consensus No. 3. American College of Obstetricians and Gynecologists [J]. Obstet Gynecol, 2015, 126: e82-e94.
[13]
American College of Obstetricians and Gynecologists. Antenatal Corticosteroid Therapy for Fetal Maturation. Committee Opinion No. 677 [J]. Obstet Gynecol, 2016, 128: e187-e194.
[14]
Antenatal corticosteroids revisited: repeat courses [J]. NIH Consens Statement, 2000, 17(2): 1-18.
[15]
Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal betamethasone for women at risk for late preterm delivery. NICHD Maternal-Fetal Medicine Units Network [J]. N Engl J Med, 2016, 374(14): 1311-1320.
[16]
Crowther CA, McKinlay CJ, Middleton P, et al. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes [J]. Cochrane Database of Systematic Reviews, 2015, (7): CD003935.
[17]
中华医学会妇产科学分会产科学组,早产临床诊断与治疗指南 [J]. 中华妇产科杂志,2014, 49(7): 481-485.
[18]
Society for Maternal-Fetal Medicine(SMFM). Publications committee. Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery [J]. Am J Obstet Gynecol, 2016, 215(2): B13-B15.
[19]
Shields A, Thomson M, Winter V, et al. Repeated courses of antenatal corticosteroids have adverse effects on aspects of brain development in naturally delivered baboon infants [J]. Pediatr Res, 2012, 71(6): 661-667.
[20]
American College of Obstetricians and Gynecologists Committee on Obstetric Practice, Society for Maternal-Fetal Medicine.Committee Opinion No.455: Magnesium sulfate before anticipated preterm birth for neuroprotection [J]. Obstet Gynecol, 2010, 115: 669-671.
[21]
SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection [J]. J Obstet Gynecol Can, 2011, 33(5): 516-529.
[22]
Marret S, Doyle LW, Crowther CA, et al. Antenatal magnesium sulphate neuroprotection in the preterm infant [J]. Semin Fetal Neonatal Med, 2007, 12(4): 311-317.
[23]
American College of Obstetricians and Gynecologists.Practice Bulletin No.159: Management of Preterm Labor [J]. Obstet Gynecol, 2016, 127(1): 29-38.
[24]
Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes [J]. Cochrane Database of Systematic Reviews, 2010, 8: CD001058.
[25]
Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broadspectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial [J]. Lancet, 2001, 357(926): 979-988.
[1] 李志文, 李远志, 李华, 方志远. 糖皮质激素治疗膝骨关节炎疗效的网状Meta分析[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 484-496.
[2] 费一鸣, 刘卓, 张丽娟. 组学分析在早产分子机制中的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 504-510.
[3] 黄蓉, 梁自毓, 祁文瑾. NLRP3炎症小体在胎膜早破孕妇血清中的表达及其意义[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 540-548.
[4] 韩肖燕, 杨桦. 中孕期孕妇血清胎盘生长因子水平低与胎儿不良预后的关系[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 398-402.
[5] 徐志刚, 曹涛, 何亭, 李博奥, 魏婧韬, 张栋梁, 官浩, 杨薛康. 采用抗生素骨水泥治疗糖尿病患者心脏术后胸骨骨髓炎的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 498-502.
[6] 姜珊, 李湘燕, 田硕涵, 温冰, 何睿, 齐心. 采用优化抗感染治疗模式改善糖尿病足感染预后的临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 398-403.
[7] 王石林, 叶继章, 丘向艳, 陈桂青, 邹晓敏. 慢性阻塞性肺疾病真菌感染风险早期预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 773-776.
[8] 刘松, 张进召, 贾艳云. 帕博利珠单抗治疗晚期非小细胞肺癌反应降低与抗生素预处理的关系[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 553-557.
[9] 黄映兰, 骆丽萍, 郭慧玲, 袁麟标. 慢性阻塞性肺疾病糖皮质激素治疗反应性的影响因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 469-471.
[10] 王涛, 刘静, 高玉伟, 王兴华, 胡秀红, 崔红蕊, 徐保振, 杨洪娟. 抗生素耐药背景下中医药防治腹膜透析相关性腹膜炎研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 340-344.
[11] 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识编写组. 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 313-324.
[12] 王倩, 李敏, 白璐, 王保兴, 李英. 结节病肾损害的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 397-401.
[13] 陈磊, 高苏俊, 王璐, 倪修凡, 史茜菁, 朱振. 糖皮质激素序贯疗法预防环周食管浅表肿瘤内镜黏膜下剥离术后狭窄的研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 159-165.
[14] 粟睿, 周璇, 杨殊琳, 方晨韵, 陈素华, 邓东锐, 曾万江, 刘海意, 龚洵, 吴媛媛, 刘燕燕, 肖娟, 余俊, 何梦舟, 李淑芳, 王子琢, 林星光, 乌剑利, 王少帅, 岳静, 靳镭, 冯玲, 丁文成. 经辅助生殖技术妊娠患者早产的影响因素分析[J/OL]. 中华产科急救电子杂志, 2024, 13(03): 168-175.
[15] 朱镭, 朱庆义. 金氏菌属:引起婴幼儿侵袭性传染病的新发病原体[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(04): 229-237.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?